Now, if what is being stated is true, then:
1) why doesn't Novavax provide a similar explanation for the failed trial
2) why doesn't Novavax provide what will be their action to move beyond that failure?
Seems that Novavax can regain some of their credibility by explaining that the vaccine is still viable and that Novavax (and the industry as a whole) gained much information from the failed Phase 3 trial.
Is the silence from Novavax just another example of Novavax management incompetence????
Or, does such a response require time to gather, review & formulate the information in a presentable fashion? Maybe such information is worthy of a medical publication?
Dunno... but the silence from Novavax management and their insider selling doesn't help.